Jack Chia Industries (Thailand) Public Company Limited

JCT.BK

Medical - Pharmaceuticals · Healthcare

Price

81.75 THB

+0.00 (+0.00%)

Market Cap

1.10B THB

Exchange

Stock Exchange of Thailand

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 9, 2026 · filings through Mar 31, 2026

Jack Chia Industries (Thailand) Public Company Limited, together with its subsidiaries, manufactures and distributes pharmaceutical and cosmetic products in Thailand. The company operates in two segments, Pharmaceutical Products and Other Consumer Products. It offers medical supplies, wound care equipment, sports tapes, and hygiene products under the Tigerplast and Tensoplast brands; cosmetic products comprising perfume, soap, shower gel, powders, etc. under the Tabu brand; eucalyptus health products and household items under the Kangaroo brand; hot compress products under the Thermaplast brand; candy products under the Jason brand; multipurpose lighter fluid products under the Ronsonol brand; and agricultural tape products and cockfighting tapes under the Golden Lion brand. The company was founded in 1966 and is based in Bangkok, Thailand.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+19.8% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Cash Position

Cash flow positive

$643M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Jack Chia Industries (Thailand) Public Company Limited is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 13.5M (2021) → 13.5M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

46.7%

Healthy — 46.7% gross margin

Operating Margin

17.4%

Healthy — 17.4% operating margin

ROCE

2.7%

Weak — 2.7% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+6.9%

Slow sales growth (+6.9% YoY)

EPS YoY

+22.3%

Earnings growing fast (+22.3% YoY)

Healthy double-digit earnings growth — what compounders look like.

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

89%

Modest — 89% of profit becomes cash

FCF Margin

10.2%

Modest free cash flow (10.2%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

168.29x

Comfortably covers interest (168.3x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

9.0x

Attractive valuation — P/E 9.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield

5.87%

Healthy income — 5.87% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend Growth

+14.0%

Dividend growing fast (14.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial